This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Beta thalassaemia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The beta thalassaemias are a group of diseases characterised by deficient synthesis of the beta-globin gene on chromosome 11. It is inherited as an Autosomal Recessive pattern (except for vary rare 'dominant thalassaemia' mutations) (1).

Approximately 1.5% of the global population are heterozygous (carriers) for beta-thalassaemias (2) and the beta thalassaemias are particularly prevalent in the Mediterranean, the Middle East, India, Pakistan and surrounding areas, and the Far East (3). These populations are most affected because they originated in areas of the world where malaria was found and being a beta thalassaemia carrier provides slight protection against malaria.

It is estimated that over 90% of children born with significant beta-thalassaemia syndromes are from Asia, India, and the Middle East, and a large number involve haemoglobin E mutations (4).

 

References:

1. Standards for the Clinical Care of Children and Adults with Thalassaemia in the UK, United Kingdom Thalassaemia Society 2008

2. De Sanctis V, Kattamis C, Canatan D, et al. β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint. Mediterr J Hematol Infect Dis. 2017;9(1)

3. Flint J, Harding RM, Boyce AJ, et al. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol. 1993 Mar;6(1):215-62.

4. Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of beta-thalassemias and hemoglobin E disorders. Expert Rev Hematol. 2010 Feb;3(1):103-17.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.